David Lubner

David Lubner is recorded as Board Member at Crescent Biopharma, Inc. (CBIO). The newest filing on record that lists David Lubner as Board Member at Crescent Biopharma, Inc. (CBIO) is dated April 21, 2026. Earlier roles on record: Board Member at Disc Medicine, Inc. (IRON) until December 29, 2022 and Board Member at Arcellx, Inc. until April 28, 2026. Vor Biopharma Inc. reported in an 8-K filed August 27, 2025 that David Lubner resigned as Director, effective August 26, 2025. Crescent Biopharma, Inc. reported in an 8-K filed July 31, 2025 that David Lubner was appointed board of directors. Crescent Biopharma, Inc. reported in an 8-K filed June 18, 2025 that David Lubner was appointed director, effective June 13, 2025. Equibles holds 4 filed executive changes naming David Lubner; each is listed under recent activity with its source filing. Crescent Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Crescent Biopharma, Inc. includes Joshua Brumm (CEO and Board Member), Peter Harwin (Chairman and Board Member), Richard Scalzo (CFO) and 7 others.